Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis

This cohort study examines Medicare Part D formulary coverage of disease-modifying therapies for patients with multiple sclerosis, comparing coverage of brand-name and generic drugs.

Corresponding Author: Jalpa A. Doshi, PhD, University of Pennsylvania, 423 Guardian Dr, Blockley Hall, Room 1223, Philadelphia, PA 19104 (jdoshi@pennmedicine.upenn.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.